Depemokimab

Depemokimab (GSK-3511294) is a long-acting anti-IL-5 monoclonal antibody. Depemokimab can be used for research of asthma[1][2].

Product Specifications

CAS Number

[2243274-14-6]

Product Name Alternative

GSK-3511294

UNSPSC

12352203

Target

Interleukin Related

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/depemokimab.html

Purity

95.24

Solubility

10 mM in DMSO

Smiles

[Depemokimab]

Molecular Weight

(145.8 kDa)

References & Citations

[1]Calzetta L, et al. Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines. 2022 Sep 19;10 (9) :2330. |[2]Singh D, et al. A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma. Br J Clin Pharmacol. 2022 Feb;88 (2) :702-712.